Role of oxidative stress in the pathogenesis of vitiligo with special emphasis on the antioxidant action of narrowband ultraviolet B phototherapy

Journal of International Medical Research

Volumn 42, Issue 3, 2014, Pages 799-805

  Karsli, Neslihan ^a   Akcali, Cenk ^b   Ozgoztasi, Orhan ^b   Kirtak, Necmettin ^b   Inaloz, Serhat ^b  

^a Department of Ophthalmology Primer Private Hospital   (Turkey)

^b GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

erythrocyte glutathione peroxidase activity; erythrocyte malonyldialdehyde; erythrocyte superoxide dismutase; GSH Px; narrowband UVB phototherapy; oxidative stress; Vitiligo

Indexed keywords

GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ERYTHROCYTE; FAMILY HISTORY; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; PATHOGENESIS; PHOTOTHERAPY; PHOTOTHERAPY DEVICE; THERAPY EFFECT; ULTRAVIOLET B RADIATION; VITILIGO; ADOLESCENT; AGED; BLOOD; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; PATHOLOGY; RADIATION RESPONSE; TREATMENT OUTCOME; ULTRAVIOLET PHOTOTHERAPY; ULTRAVIOLET RADIATION;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; ERYTHROCYTES; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; TREATMENT OUTCOME; ULTRAVIOLET RAYS; ULTRAVIOLET THERAPY; VITILIGO;

EID: 84904761457     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060513516294     Document Type: Article

References (28)

1. Nicolaidou E,Antoniou C,Stratigos A, et al.Narrowband ultraviolet B phototherapy and 308-nm excimer laser in the treatment of vitiligo: a review.J Am Acad Dermatol. 2009;60:470-477.
2. Passeron T,Ortonne JP.Physiopathology and genetics of vitiligo.J Autoimmun. 2005;25:63-68.
3. Abu Tahir M,Pramod K,Ansari SH, et al.Current remedies for vitiligo.Autoimmun Rev. 2010;9:516-520.
4. Halder RM,Chappell JL.Vitiligo update.Semin Cutan Med Surg. 2009;28:86-92.
5. Rokos H,Beazley WD,Schallreuter KU.Oxidative stress in vitiligo: photo-oxidation of pterins produces H(2)O(2) and pterin-6-carboxylic acid.Biochem Biophys Res Commun. 2002;292:805-811.
6. Westerhof W,Nieuweboer-Krobotova L.Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.Arch Dermatol. 1997;133:1525-1528.
7. Elgoweini M,Nour El Din N.Response of vitiligo to narrowband ultraviolet B and oral antioxidants.J Clin Pharmacol. 2009;49:852-855.
8. Gawkrodger DJ,Ormerod AD,Shaw L, et al.Guideline for the diagnosis and management of vitiligo.Br J Dermatol. 2008;159:1051-1076.
9. Antoniou C,Katsambas A.Guidelines for the treatment of vitiligo.Drugs. 1992;43:490-498.
10. Kanwar AJ,Dogra S.Narrow-band UVB for the treatment of generalized vitiligo in children.Clin Exp Dermatol. 2005;30:332-336.
11. Sun Y,Oberley LW,Li Y.A simple method for clinical assay of superoxide dismutase.Clin Chem. 1988;34:497-500.
12. Jain SK,McVie R,Duett J, et al.Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes.Diabetes. 1989;38:1539-1543.
13. Paglia DE,Valentina WN.Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase.J Lab Clin Med. 1967;70:158-169.
14. Picardo M,Passi S,Morrone A, et al.Antioxidant status in the blood of patients with active vitiligo.Pigment Cell Res. 1994;7:110-115.
15. Koca R,Armutcu F,Altinyazar HC, et al.Oxidant-antioxidant enzymes and lipid peroxidation in generalized vitiligo.Clin Exp Dermatol. 2004;29:406-409.
16. Passi S,Grandinetti M,Maggio F, et al.Epidermal oxidative stress in vitiligo.Pigment Cell Res. 1998;11:81-85.
17. Hazneci E,Karabulut AB,Oztürk C, et al.A comparative study of superoxide dismutase, catalase, and glutathione peroxidase activities and nitrate levels in vitiligo patients.Int J Dermatol. 2005;44:636-640.
18. Ines D,Sonia B,Riadh BM, et al.A comparative study of oxidant-antioxidant status in stable and active vitiligo patients.Arch Dermatol Res. 2006;298:147-152.
19. Yildirim M,Baysal V,Inaloz HS, et al.The role of oxidants and antioxidants in generalized vitiligo at tissue level.J Eur Acad Dermatol Venereol. 2004;18:683-686.
20. Agrawal D,Shajil EM,Marfatia YS, et al.Study on the antioxidant status of vitiligo patients of different age groups in Baroda.Pigment Cell Res. 2004;17:289-294.
21. Beazley WD,Gaze D,Panske A, et al.Serum selenium levels and blood glutathione peroxidase activities in vitiligo.Br J Dermatol. 1999;141:301-303.
22. Boisseau-Garsaud AM,Garsaud P,Lejoly-Boisseau H, et al.Increase in total blood antioxidant status and selenium levels in black patients with active vitiligo.Int J Dermatol. 2002;41:640-642.
23. Yildirim M,Baysal V,Inaloz HS, et al.The role of oxidants and antioxidants in generalized vitiligo.J Dermatol. 2003;30:104-108.
24. Bhatnagar A,Kanwar AJ,Parsad D, et al.Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study.J Eur Acad Dermatol Venereol. 2007;21:638-642.
25. Yones SS,Palmer RA,Garibaldinos TM, et al.Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs narrowband-UV-B therapy.Arch Dermatol. 2007;143:578-584.
26. Colucci R,Lotti T,Moretti S.Vitiligo: an update on current pharmacotherapy and future directions.Expert Opin Pharmacother. 2012;13:1885-1899.
27. Natta R,Somsak T,Wisuttida T, et al.Narrowband ultraviolet B radiation therapy for recalcitrant vitiligo in Asians.J Am Acad Dermatol. 2003;49:473-476.
28. Dell'Anna ML,Mastrofrancesco A,Sala R, et al.Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.Clin Exp Dermatol. 2007;32:631-636.